Presentation Information

[1SP-25-11 (1P-0565)]Screening and evaluation of isoliquiritigenin derivatives targeting aberrant activation of the CAPS-associated NLRP3-D303N mutant

○Reiji Ogawa1, Miho Ito1, Hiroe Honda2, Tadayoshi Karasawa3, Fumitake Usui-Kawanishi1, Yoshinori Nagai1 (1. Grad. Sch. of Eng., Biotechnology, Toyama Pref. Univ., 2.Toyama Pref. Inst. Pharm. Res., 3.Div. Inflammation Res., Ctr. Mol. Med., Jichi Med. Univ.)

Password required to view

Password required to view or download.
Check your name badge for the password.

Comment

To browse or post comments, you must log in.Log in